Unleashing the power of proteomics to develop blood-based cancer markers.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1373/clinchem.2012.184572PMID 23099557PMCID PMC5939937
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protein tag-mediated conjugation of oligonucleotides to recombinant affinity binders for proximity ligation.

  2013cited by this paper
• Electrical detection of cancer biomarker using aptamers with nanogap break-junctions

  2012cited by this paper
• Advances in human proteomics at high scale with the SOMAscan proteomics platform.

  2012cited by this paper
• Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer.

  2012cited by this paper
• The current status of clinical proteomics and the use of MRM and MRM3 for biomarker validation

  2012cited by this paper
• Sensitive detection of proteins using assembled cascade fluorescent DNA nanotags based on rolling circle amplification.

  2012cited by this paper
• Antibody array analysis of labelled proteomes: how should we control specificity?

  2012cited by this paper
• A proteomics platform combining depletion, multi-lectin affinity chromatography (M-LAC), and isoelectric focusing to study the breast cancer proteome.

  2011cited by this paper
• Mining the plasma proteome for disease applications across seven logs of protein abundance.

  2011cited by this paper
• Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.

  2011cited by this paper
• Ultra High Resolution Linear Ion Trap Orbitrap Mass Spectrometer (Orbitrap Elite) Facilitates Top Down LC MS/MS and Versatile Peptide Fragmentation Modes*

  2011cited by this paper
• Integrated mass spectrometry–based analysis of plasma glycoproteins and their glycan modifications

  2011cited by this paper
• Cancer biomarkers: closer to delivering on their promise.

  2011cited by this paper
• Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening: A Randomized Trial

  2011cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• Discovery and validation of ovarian cancer biomarkers utilizing high density antibody microarrays

  2010cited by this paper
• Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer

  2010cited by this paper
• Autoassembly Protein Arrays for Analyzing Antibody Cross-Reactivity

  2010cited by this paper
• The grand challenge to decipher the cancer proteome

  2010cited by this paper
• Mass spectrometry in high-throughput proteomics: ready for the big time

  2010cited by this paper
• Cumulative Incidence of False-Positive Test Results in Lung Cancer Screening

  2010cited by this paper
• Cost of Breast-Related Care in the Year Following False Positive Screening Mammograms

  2010cited by this paper
• Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera.

  2009cited by this paper
• Matrix-insensitive protein assays push the limits of biosensors in medicine

  2009cited by this paper
• SISCAPA Peptide Enrichment on Magnetic Beads Using an In-line Bead Trap Device*S

  2009cited by this paper
• Metabolomics of cancer.

  2009cited by this paper
• Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.

  2008cited by this paper
• Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera.

  2008cited by this paper
• Human Proteinpedia enables sharing of human protein data

  2008cited by this paper
• Mining the plasma proteome for cancer biomarkers

  2008cited by this paper
• Identification of 14-3-3θ as an antigen that induces a humoral response in lung cancer

  2007cited by this paper
• Mass Spectrometric Detection of Tissue Proteins in Plasma*S

  2007cited by this paper
• Lung cancer screening with low-dose computed tomography: Canadian experience.

  2007cited by this paper
• Metabolomics: available results, current research projects in breast cancer, and future applications.

  2007cited by this paper
• Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.

  2007cited by this paper
• Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.

  2007cited by this paper
• Circulating cell-free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool.

  2006cited by this paper
• ELISA microarray technology as a high-throughput system for cancer biomarker validation

  2006cited by this paper
• UniPep - a database for human N-linked glycosites: a resource for biomarker discovery

  2006cited by this paper
• Lung Cancer Screening Using Multi-Slice Thin-Section Computed Tomography and Autofluorescence Bronchoscopy

  2006cited by this paper
• Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study

  2006cited by this paper
• PRIDE: a public repository of protein and peptide identifications for the proteomics community

  2005cited by this paper
• Glycans in cancer and inflammation — potential for therapeutics and diagnostics

  2005cited by this paper
• Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database

  2005cited by this paper
• Human Plasma PeptideAtlas

  2005cited by this paper
• CT screening for lung cancer: five-year prospective experience.

  2005cited by this paper
• Open source system for analyzing, validating, and storing protein identification data.

  2004cited by this paper
• Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings.

  2004cited by this paper
• Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

  2003cited by this paper
• Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers.

  2002cited by this paper
• Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies.

  2002cited by this paper
• Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project.

  2002cited by this paper
• Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer.

  2001cited by this paper
• Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner

  2001cited by this paper
• An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer

  2001cited by this paper
• DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

  2001cited by this paper
• Early Lung Cancer Action Project

  2001cited by this paper
• Screening for lung cancer with low-dose spiral computed tomography.

  2000cited by this paper
• Early Lung Cancer Action Project: overall design and findings from baseline screening.

  1999cited by this paper
• Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography.

  1996cited by this paper
• Breast Cancer Diagnosis and Prognosis through Quantitative Measurements of Serum Glycan Profiles

  year unknowncited by this paper

• Magnetic microspheres enhanced peanut structure cascaded lasso shaped fiber laser biosensor for cancer marker-CEACAM5 detection in serum.

  2024cites this paper
• Mechanistic insight into glioma through spatially multidimensional proteomics

  2024cites this paper
• Fiber Laser-Based Lasso-Shaped Biosensor for High Precision Detection of Cancer Biomarker-CEACAM5 in Serum

  2023cites this paper
• The Simple prEservatioN of Single cElls method for cryopreservation enables the generation of single-cell immune profiles from whole blood

  2023cites this paper
• Clinical applications of plasma proteomics and peptidomics: Towards precision medicine

  2022cites this paper
• Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer

  2022cites this paper
• An evaluation of the National Institutes of Health grants portfolio: identifying opportunities and challenges for multi-omics research that leverage metabolomics data

  2022cites this paper
• Psoriasis to Psoriatic Arthritis: The Application of Proteomics Technologies

  2021cites this paper
• Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden.

  2020cites this paper
• Investigating a novel multiplex proteomics technology for detection of changes in serum protein concentrations that may correlate to tumor burden

  2020cites this paper
• An Integrated Quantitative Proteomics Workflow for Cancer Biomarker Discovery and Validation in Plasma

  2020cites this paper
• Mass Spectrometry-Based Plasma Proteomics: Considerations from Sample Collection to Achieving Translational Data

  2019cites this paper
• Applications of serum amino acid levels in identification of cancer

  2019cites this paper
• Revisiting the Hallmarks of Aging to Identify Markers of Biological Age

  2019cites this paper
• Optimization and Standardization of Thermal Treatment as a Plasma Prefractionation Method for Proteomic Analysis

  2019cites this paper
• Modulating the protein content of complex proteomes using acetonitrile.

  2018cites this paper
• Mining the acidic serum proteome utilizing off-gel isoelectric focusing and label free quantitative liquid chromatography mass spectrometry.

  2018cites this paper
• Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening

  2017cites this paper
• Plasma prefractionation methods for proteomic analysis and perspectives in clinical applications

  2017cites this paper
• Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis.

  2016cites this paper
• Thyroid hormone testing in the 21st century.

  2016cites this paper
• An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.

  2016cites this paper
• Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives

  2016cites this paper
• Deciphering the complexity of the cancer proteome for diagnostic applications

  2016cites this paper
• Targeted mass spectrometry analysis of the proteins IGF1, IGF2, IBP2, IBP3 and A2GL by blood protein precipitation.

  2015cites this paper
• Proteomic Signature of Endothelial Dysfunction Identified in the Serum of Acute Ischemic Stroke Patients by the iTRAQ-Based LC-MS Approach.

  2015cites this paper
• Rapid Slow Off-Rate Modified Aptamer (SOMAmer)-Based Detection of C-Reactive Protein Using Isotachophoresis and an Ionic Spacer.

  2015cites this paper
• DIGESTIF: a universal quality standard for the control of bottom-up proteomics experiments.

  2015cites this paper
• Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia

  2014cites this paper
• Ensembles of protein termini and specific proteolytic signatures as candidate biomarkers of disease

  2014cites this paper
• KYSS: mass spectrometry data quality assessment for protein analysis and large-scale proteomics.

  2014cites this paper
• Unleashing the Power of Proteomics to Develop Blood-Based Cancer Markers

  2014cites this paper
• Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.

  2014cites this paper
• Proteomic analysis of tissue samples in translational breast cancer research

  2014cites this paper
• Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.

  2014cites this paper
• Autoantibodies in breast cancer.

  2014cites this paper
• Towards paper-based point of care affinity proteomics

  2014cites this paper
• Proximal fluid proteomics for the discovery of digestive cancer biomarkers.

  2014cites this paper
• Point-of-care vertical flow allergen microarray assay: proof of concept.

  2014cites this paper
• Dimethylnitrosamine-induced reduction in the level of poly-ADP-ribosylation of histone proteins of blood lymphocytes--a sensitive and reliable biomarker for early detection of cancer.

  2014cites this paper
• Generation of miniaturized planar ecombinant antibody arrays using a microcantilever-based printer

  2014cites this paper
• Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case–control studies

  2014cites this paper
• Building a map of the breast cancer proteome - Strategies to increase coverage

  2013cites this paper
• Analysis of blood-based markers as predicting tools of pathologic tumour response in rectal cancer patients receiving neo-adjuvant chemoradiotherapy

  2013cites this paper
• Blood microvesicles: From proteomics to physiology

  2013cites this paper
• Mass Spectrometry Applications in Clinical Diagnostics

  2013cites this paper
• Comparison of urinary and serum CA 19-9 as markers of early stage urothelial carcinoma.

  2013cites this paper
• The Application of SILAC Mouse in Human Body Fluid Proteomics Analysis Reveals Protein Patterns Associated with IgA Nephropathy

  2013cites this paper
• Proteomic analysis of venous thromboembolism: an update

  2013cites this paper
• Multivariate analysis of cancer proteomics data : towards a biological systems view and understanding

  2013cites this paper